v3.26.3
Consolidated Statements of Comprehensive Income - AUD ($)
 12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2024
Revenue      
License revenue $ 14,556,923 $ 0 $ 0
Other income      
Research material sales 38,607 59,709 119,089
Grant income 5,338,572 4,974,823 3,722,788
Net gain on foreign exchange 1,229,851 0 113,458
Fair value gain on financial assets 0 9,242 0
Interest income 3,005,047 5,287,209 3,882,757
Miscellaneous 0 390 533
Total revenue and other income 24,169,000 10,331,373 7,838,625
Expenses      
Research & development and intellectual property expenses (91,946,919) (61,410,533) (41,546,724)
Corporate administrative expenses (9,579,329) (8,644,503) (8,852,615)
Net loss on foreign exchange 0 (1,529,309) 0
Finance costs (67,896) (37,078) (30,594)
Net Changes in fair value of convertible note liability (11,318) (144,115) (125,317)
Net change in fair value of derivative financial instrument (1,868,101) 0 0
Loss before income tax expense (79,304,563) (61,434,165) (42,716,625)
Income tax expense 0 0 0
Loss after income tax expense for the year (79,304,563) (61,434,165) (42,716,625)
Other Comprehensive Income/(Loss)      
Exchange differences on the translation of foreign operations (5,503,724) 14,384,243 (1,421,191)
Other comprehensive income/(loss) for the year, net of tax (5,503,724) 14,384,243 (1,421,191)
Total comprehensive loss for the year (84,808,287) (47,049,922) (44,137,816)
Loss for the year is attributable to:      
Owners of Immutep Limited (79,304,563) (61,434,165) (42,716,625)
Total comprehensive loss for the year is attributable to:      
Owners of Immutep Limited $ (84,808,287) $ (47,049,922) $ (44,137,816)
Basic loss per share $ (0.0539) $ (0.0422) $ (0.0356)
Diluted loss per share $ (0.0539) $ (0.0422) $ (0.0356)